Fundraising FoxST Renatus
Ft Collins, US · Delaware LLC
Find your way into ST Renatus
Sign up to see every warm intro you have to ST Renatus
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ST Renatus team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PS
Paul SlettenExecutive
MA
Martin A. Culhane IIIExecutive
JM
Jill M. ShoemakerExecutive
RW
Ronald W. HartExecutive
ST
Steven T. MerrickNamed on SEC filing
Board
JP
James P. MulvahillBoard director
SD
Stephen D. TeboBoard director
MA
Martin A. CulhaneBoard director
JM
Jerry MorgensenBoard director
MD
Mark D. KollarBoard director
EL
Eric LodewijkBoard director
BM
Brent M. T. KeeleBoard director
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 3 of 4 rounds · 2013–2018
▶$26MofferedJun 2018 · PharmaceuticalsRule 506(b)
▶$26MofferedJun 2018 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James L ParkeDirector
- Stephen D TeboDirector
- Brent M T KeeleDirector
- Jerry M MorgensenDirector
- Joesph D Schofield IIIDirector
- Terence M TuckerExecutive Officer
- Frank R RamirezExecutive Officer, Director
- Offering amount
- $26M
- Minimum investment
- $25.1K
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedApr 2017 · 6 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedApr 2017 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jerry MorgensenDirector
- Steven T. MerrickExecutive Officer
- Mark D. KollarDirector
- Eric LodewijkDirector
- Paul SlettenExecutive Officer
- Martin A. Culhane IIIExecutive Officer
- Brent M. T. KeeleDirector
- James P. MulvahillDirector
- Jill M. ShoemakerExecutive Officer
- Frank R. RamirezDirector
- Stephen D. TeboDirector
- Offering amount
- $9M
- Amount sold
- $1.1M
- Minimum investment
- $50K
- Proceeds to insiders
- $500K
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$65KraisedSep 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$65KraisedSep 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steve T. MerrickExecutive Officer, Director
- Ronald W. HartExecutive Officer, Director
- Jill M. ShoemakerExecutive Officer
- James P. MulvahillDirector
- Martin A. CulhaneDirector
- Christopher M. ScottiDirector
- Mark D. KollarDirector
- Kurt HoevenDirector
- Steve SnyderDirector
- Offering amount
- $2.1M
- Amount sold
- $65K
- Minimum investment
- $52K
- Proceeds to insiders
- $308.7K
- First sale
- Aug 2014
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$66.3KraisedJan 2014 · 3 investors · Other Health CareRule 506(b)
▶$66.3KraisedJan 2014 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin A. CulhaneDirector
- Mark D. KollarDirector
- James P. MulvahillDirector
- Ronald W. HartExecutive Officer, Director
- Frank R. RamirezDirector
- Jill M. ShoemakerExecutive Officer
- Steven T. MerrickExecutive Officer, Director
- Christopher M. ScottiDirector
- Offering amount
- $2.5M
- Amount sold
- $66.3K
- Minimum investment
- $25K
- Proceeds to insiders
- $315K
- First sale
- Dec 2013
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ST Renatus raised?
- ST Renatus has disclosed $1.2M raised across 3 of its 4 known rounds.
- Where is ST Renatus headquartered?
- ST Renatus is headquartered in Ft Collins, US.